Obstructive hypertrophic cardiomyopathy
Conditions
Interventions
Observation group:None
Sponsors
Department of Ultrasound, The First Affiliated Hospital of the Air Force Medical University (Xijing Hospital).
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1) Enrollment age>=18 years old; 2) Obstructive hypertrophic cardiomyopathy treated by PIMSRA ablation from June 2016 to May 2024; 3) Able to understand the purpose of the clinical trial, voluntarily participate and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1) Non-obstructive hypertrophic cardiomyopathy; 2) The investigator judged that the patient's compliance was poor and the patient could not complete the study as required, resulting in incomplete clinical data.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Left ventricular outflow tract pressure gradient (LVOT gradient) decreased by >=50% or resting left ventricular outflow tract gradient (LVOT gradient) <30 mmHg) ;Death was witnessed within 30 days of surgery;Symptomatic onset and 1 hour death within 30 days after surgery;Symptoms did not worsen within 30 days after surgery, and died at night;Sudden cardiac death (SCD) within 30 days after surgery was saved; The ICD was appropriately discharged within 30 days after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Ventricular septal thickness ;New York Heart Association Functional Classification, NYHA Grade;The left ventricular outflow tract pressure gradient (LVOT pressure gradient) decreased by >=50% or the resting left ventricular outflow tract pressure gradient (LVOT pressure gradient) decreased by <30 mmHg.;Malignant arrhythmias occurred during surgery and within 30 days after surgery;Intraoperative and 30 days postoperatively require drainage and/or surgical cardiac tamponade;Ventricular septal hematoma/ventricular septal perforation requiring emergency surgery intraoperatively and 30 days postoperatively;Cardiogenic shock during and 30 days after surgery;Postoperative thromboembolic events; | — |
Countries
China
Contacts
Public ContactLiwen Liu
The First Affiliated Hospital of Air Force Military Medical University (Xijing Hospital)
Outcome results
None listed